HER2-positive gastric cancer
N Boku - Gastric cancer, 2014 - Springer
Human epidermal growth factor receptor 2 (HER2) is involved in the pathogenesis and poor
outcomes of several types of cancer, including advanced gastric and gastroesophageal …
outcomes of several types of cancer, including advanced gastric and gastroesophageal …
The role of the insulin/IGF system in cancer: lessons learned from clinical trials and the energy balance-cancer link
LW Bowers, EL Rossi, CH O'Flanagan… - Frontiers in …, 2015 - frontiersin.org
Numerous epidemiological and pre-clinical studies have demonstrated that the
insulin/insulin-like growth factor (IGF) system plays a key role in the development and …
insulin/insulin-like growth factor (IGF) system plays a key role in the development and …
Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome
MD Begnami, E Fukuda, JHTG Fregnani… - Journal of clinical …, 2011 - ascopubs.org
Purpose The human epidermal growth factor receptor (HER) family consists of four
members: ErbB-1 (HER1), ErbB-2 (HER2), ErbB-3 (HER3), and ErbB-4 (HER4). These …
members: ErbB-1 (HER1), ErbB-2 (HER2), ErbB-3 (HER3), and ErbB-4 (HER4). These …
[HTML][HTML] Targeted therapies for gastric cancer: failures and hopes from clinical trials
M Apicella, S Corso, S Giordano - Oncotarget, 2017 - ncbi.nlm.nih.gov
Gastric cancer is the third leading cause of cancer mortality worldwide. As surgery is the only
curative treatment strategy and conventional chemotherapy has shown limited efficacy-with …
curative treatment strategy and conventional chemotherapy has shown limited efficacy-with …
Clinicopathologic factors associated with HER2‐positive gastric cancer and its impact on survival outcomes—A systematic review
TC Chua, ND Merrett - International journal of cancer, 2012 - Wiley Online Library
With the availability of a therapeutic target and an effective agent in trastuzumab, a
systematic examination of the literature to investigate the role of human epidermal growth …
systematic examination of the literature to investigate the role of human epidermal growth …
Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma
AK Nagatsuma, M Aizawa, T Kuwata, T Doi, A Ohtsu… - Gastric cancer, 2015 - Springer
Background Some tyrosine kinase receptors (RTKs) play critical roles in gastric cancer
progression. Not only trastuzumab, but also several other agents targeting RTKs are being …
progression. Not only trastuzumab, but also several other agents targeting RTKs are being …
[HTML][HTML] Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer: a systematic review and meta-analysis
F Petrelli, R Berenato, L Turati, A Mennitto… - Journal of …, 2017 - ncbi.nlm.nih.gov
Background There are two distinct types of gastric carcinoma (GC), intestinal, more
frequently sporadic and linked to environmental factors, and diffuse (undifferentiated) that is …
frequently sporadic and linked to environmental factors, and diffuse (undifferentiated) that is …
Host inflammatory response predicts survival of patients with Epstein-Barr virus–associated gastric carcinoma
BACKGROUND & AIMS: Lymphoepithelioma-like carcinoma (LELC) is a rare subtype of
gastric carcinoma (GC) with a better survival rate than other GCs; most cases of LELC are …
gastric carcinoma (GC) with a better survival rate than other GCs; most cases of LELC are …
Dysregulation of cellular signaling in gastric cancer
The pathogenesis of gastric cancer is complex and related to multiple factors. Dysregulation
of intracellular signaling pathways represents a common pathogenic mechanism and may …
of intracellular signaling pathways represents a common pathogenic mechanism and may …
Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients
N Fuse, Y Kuboki, T Kuwata, T Nishina, S Kadowaki… - Gastric cancer, 2016 - Springer
Background This study was conducted to investigate whether human epidermal growth
factor receptor 2 (HER2) status, epidermal growth factor receptor (EGFR) status, and c-MET …
factor receptor 2 (HER2) status, epidermal growth factor receptor (EGFR) status, and c-MET …